Pilot study of valganciclovir in patients with classic, non-HIV-associated Kaposi's sarcoma

Trial Profile

Pilot study of valganciclovir in patients with classic, non-HIV-associated Kaposi's sarcoma

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Nov 2015

At a glance

  • Drugs Valganciclovir (Primary)
  • Indications Kaposi's sarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Mar 2013 Additional lead trial centres added as reported by ClinicalTrials.gov record.
    • 15 Apr 2008 Status changed from recruiting to completed according to clinicaltrials.gov.
    • 25 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top